HemCon Medical Technologies Inc., a Portland, Ore.-based developer of technologies to control bleeding and infection resulting from trauma or surgery, has raised $12 million in venture capital from Camden Partners and Torch Hill Partners. www.hemcon.com
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.